Home » Topics » BioWorld Science

BioWorld Science
RSS

Japan Tobacco describes cell adhesion inhibitors

Aug. 9, 1996

MK7634 described in world patent

Aug. 9, 1996

VX-478 covered under U.S. patent for HIV/AIDS

Aug. 9, 1996

RD4-2025: Selective HIV-1 reverse transcriptase inhibitor in vitro

Aug. 9, 1996

GalaGen's Sporidin G enters phase II/III

Aug. 9, 1996

Immtech's r(m)CRP HIV treatment covered under U.S. patent

Aug. 9, 1996

Cel-Sci now holds full rights to HGP-30

Aug. 9, 1996

BioChem Pharma to challenge Epivir patent

Aug. 9, 1996

A-76202: Alpha-glucosidase/sucrase-isomaltase complex inhibitor from Sankyo

Aug. 9, 1996

Emory University files Epivir patent infringement action

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...